NCT03466619 Penile Prosthesis in Patients With Erectile Dysfunction
| NCT ID | NCT03466619 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Erectile Dysfunction |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2014-11-01 |
| Primary Completion | 2027-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2014-11-01 with a primary completion date of 2027-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Erectile dysfunction (ED) is defined as the persistent inability to attain and or maintain an erection sufficient to permit satisfactory sexual performance
Eligibility Criteria
Inclusion Criteria: * Patients complaining of ED with contraindication or failure of medical treatment Exclusion Criteria: * Patients lacking manual dexterity or mental abilities necessary to operate the pump * General contraindications as uncorrectable bleeding tendency
Contact & Investigator
Khaled Mohamed Hafez Morsy Almekaty, Msc
PRINCIPAL INVESTIGATOR
Urology Department- Tanta University
Frequently Asked Questions
Who can join the NCT03466619 clinical trial?
This trial is open to male participants only, aged 18 Years or older, up to 80 Years, studying Erectile Dysfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03466619 currently recruiting?
Yes, NCT03466619 is actively recruiting participants. Contact the research team at sheriefabdelsalam@yahoo.com for enrollment information.
Where is the NCT03466619 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT03466619 clinical trial?
NCT03466619 is sponsored by Tanta University. The principal investigator is Khaled Mohamed Hafez Morsy Almekaty, Msc at Urology Department- Tanta University. The trial plans to enroll 100 participants.